No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Central Nervous System / pathology*
-
Cerebrospinal Fluid / cytology
-
Chemical and Drug Induced Liver Injury / etiology
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Dexamethasone / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Humans
-
Kaplan-Meier Estimate
-
Kidney Diseases / chemically induced
-
Leucovorin / administration & dosage
-
Lymphoma, Large B-Cell, Diffuse / cerebrospinal fluid
-
Lymphoma, Large B-Cell, Diffuse / drug therapy*
-
Lymphoma, Large B-Cell, Diffuse / pathology
-
Male
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Middle Aged
-
Mucositis / chemically induced
-
Neoplasm Invasiveness
-
Prednisone / administration & dosage
-
Proportional Hazards Models
-
Prospective Studies
-
Recurrence
-
Rituximab / administration & dosage
-
Vincristine / administration & dosage
Substances
-
Cytarabine
-
Rituximab
-
Vincristine
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide
-
Leucovorin
-
Prednisone
-
Methotrexate